Location History:
- Oslo, NO (2014 - 2015)
- Skjeberg, NO (2022)
Company Filing History:
Years Active: 2014-2022
Title: Terje Frigstad: Innovator in Molecular Biology
Introduction
Terje Frigstad is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of molecular biology, particularly in the development of innovative vector constructs and recombinant MHC class II molecules. With a total of 3 patents, Frigstad's work has implications for both research and therapeutic applications.
Latest Patents
Frigstad's latest patents include a vector construct that comprises a sequence encoding a signal peptide directing proteins into the Tat secretory pathway. This invention also features a sequence encoding a fluorophore fused to a pVIII phage coat protein. Additionally, he has developed disulphide bond-stabilized functional soluble MHC class II heterodimers. This invention provides a recombinant MHC class II molecule that includes parts of the extracellular portions of MHC class II α and β chains, linked by a disulphide bond, which enhances its functionality.
Career Highlights
Throughout his career, Terje Frigstad has worked with esteemed institutions such as the University of Oslo and Nextera AS. His research has focused on advancing the understanding of molecular mechanisms and developing innovative solutions in the field of immunology.
Collaborations
Frigstad has collaborated with notable colleagues, including Inger Sandlie and Geir Age Loset. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Terje Frigstad's contributions to molecular biology through his innovative patents highlight his role as a leading inventor in the field. His work continues to influence research and applications in immunology and biotechnology.